Products
Cyclo Therapeutics Pipeline | Rafael Holdings, Inc.
Service description
Rafael Holdings’ investment in Cyclo Therapeutics provides access to a pipeline of novel cancer therapies, specifically focused on Niemann Pick Type C1. This represents a significant opportunity to deliver a breakthrough treatment option for patients with this challenging disease.